Last update 24 Sep 2025

Allogeneic bone marrow-derived mesenchymal stem cell(The University of Texas Health Science Center)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Parkinson Disease
Originator Organization
The University of Texas Health Science Center at HoustonThe University of Texas Health Science Center at Houston
Active Organization-
Inactive Organization
The University of Texas Health Science Center at HoustonThe University of Texas Health Science Center at Houston
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Allogeneic bone marrow-derived mesenchymal stem cell(The University of Texas Health Science Center)
NCT04506073
/ CompletedPhase 2IIT
A Randomized, Double-blind, Placebo-controlled Trial of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease
100 Clinical Results associated with Allogeneic bone marrow-derived mesenchymal stem cell(The University of Texas Health Science Center)
Login to view more data
100 Translational Medicine associated with Allogeneic bone marrow-derived mesenchymal stem cell(The University of Texas Health Science Center)
Login to view more data
100 Patents (Medical) associated with Allogeneic bone marrow-derived mesenchymal stem cell(The University of Texas Health Science Center)
Login to view more data
100 Deals associated with Allogeneic bone marrow-derived mesenchymal stem cell(The University of Texas Health Science Center)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 2
United States
The University of Texas Health Science Center at HoustonThe University of Texas Health Science Center at Houston
09 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free